Dual checkpoint blockade (PD-1/PD-L1 and CTLA-4 inhibitors)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dual checkpoint blockade (PD-1/PD-L1 and CTLA-4 inhibitors), covering 2026-04-20 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas [Phase 2]